Considering the differential expression pattern of HER2 and Ki-67 mentioned above, it is reasonable to imply that the expression level of SSR3 may also contribute to the distinction of luminal breast cancer from other breast cancer subtypes. Here, ERBB2 is linked to breast cancer.